Indicator summary: Leaning bullish (3 bullish, 1 bearish, 1 neutral). As of 2026-11-05, the close was $85.92: 9.3% above the 50-day average and 4.3% above the 200-day average, which is rising. RSI (14) is 69, in its neutral range. MACD is bullish. The stock sits 70% of the way up its 52-week range of $71.46 to $92.18, on 2.0x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $78.63 | Price 9.3% above |
| 200-day average | $82.42 | Price 4.3% above, average rising |
| 50 vs 200-day | 50 below 200 | Death-cross alignment |
| RSI (14) | 69 | Neutral range |
| MACD (12, 26, 9) | +1.91 vs +1.53 | Line above signal |
| 52-week range | $71.46 to $92.18 | 70% of the way up the range |
| Volume vs 20-day average | 2.0x | Heavy |
Base rates use NGG's own daily history since 2001; they describe the past, not a forecast.
As of 2026-11-05, NGG's 14-day RSI is 69, which is in the neutral range between 30 and 70.
Yes. NGG closed at $85.92 on 2026-11-05, 4.3% above its 200-day average of $82.42, which is rising. When it closed above its 200-day average (4,449 days), it was higher 63 trading days later 61% of the time, median +2.2%.
Yes. NGG closed at $85.92 on 2026-11-05, 9.3% above its 50-day average of $78.63. When it closed above its 50-day average (3,824 days), it was higher 63 trading days later 62% of the time, median +2.6%.
No cross in the last 10 trading days. As of 2026-11-05 the MACD line is +1.91 against a signal line of +1.53, so MACD is bullish.
No. At $85.92 it sits 70% of the way up its 52-week range of $71.46 to $92.18, 6.8% below the high.
Leaning bullish: 3 of 5 indicators are bullish and 1 bearish as of 2026-11-05 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Bearish, from the chart signal model.
NGG analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.